June 29, 2017 Comments Off on Eli Lilly Unveils Expanded $90M Biotechnology Center Views: 651 California News, Healthcare News, San Diego

Eli Lilly Unveils Expanded $90M Biotechnology Center

Eli Lilly and Company completed a $90-million expansion of its Biotechnology Center in San Diego. Lilly’s new space helps foster and accelerate the discovery of medicines within the company’s core therapeutic areas of immunology, diabetes, oncology and neurodegeneration, as well as the emerging area of pain.

The new facility at 10290 Campus Point Dr. is part of the global healthcare company’s $850-million investment into expanding its U.S. operations. Lilly’s David A. Ricks said, “Today, as part of that commitment, we are pleased to say our research footprint in San Diego has been expanded.”

The center features a new technologically-advanced laboratory and an additional 180,000 square feet of working space, an increase of 145% over its former facility. In addition to the center’s established presence in preclinical and clinical immunology research, the new space allows for closer partnership between Lilly experts in biotechnology, discovery chemistry and research technologies.

Read more at Eli Lilly


Subscribe to Connect Daily California

For comments, questions or concerns, please contact Dennis Kaiser

Share on FacebookTweet about this on TwitterShare on LinkedInEmail this to someone

Tags: , , , ,

Comments are closed.